Pien Huang Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
Pien Huang
Stories By

Pien Huang

Wanyu Zhang/NPR
Pien Huang
Wanyu Zhang/NPR

Pien Huang

Reporter, Science Desk

Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.

She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.

Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.

Story Archive

Encore: Infusions of antibodies used to treat COVID are being phased out

  • Download
  • <iframe src="https://www.npr.org/player/embed/1139971255/1139976072" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The disease formerly known as monkeypox has a new name

  • Download
  • <iframe src="https://www.npr.org/player/embed/1139544117/1139544118" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Antonio Rapuano got an infusion of a monoclonal antibody to treat his COVID in Albano, Italy in 2021. Such infusions have been effective treatments for COVID during the pandemic, but doctors are now finding that most monoclonal antibodies no longer work against new variants of SARS-CoV-2. Yara Nardi/Reuters hide caption

toggle caption
Yara Nardi/Reuters

How monoclonal antibodies lost the fight with new COVID variants

  • Download
  • <iframe src="https://www.npr.org/player/embed/1137892932/1138179850" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The federal government's new opioid prescribing guidelines may help doctors better manage patients with chronic pain who need consistent doses of pain medicines. For example, one patient takes tramadol regularly for serious pain caused by osteogenesis imperfecta, or brittle bone disease. Jose M. Osorio/Tribune News Service via Getty Images hide caption

toggle caption
Jose M. Osorio/Tribune News Service via Getty Images

CDC underscores the importance of Black and Hispanic adults getting flu shots

  • Download
  • <iframe src="https://www.npr.org/player/embed/1129846156/1129846157" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Studies show that monkeypox isn't easy to catch from respiratory droplets or contaminated objects. It's one of the reasons that the virus hasn't spread more widely in the U.S. AP hide caption

toggle caption
AP

Monkeypox cases in the U.S. are way down — can the virus be eliminated?

  • Download
  • <iframe src="https://www.npr.org/player/embed/1129234501/1129247177" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Monkeypox cases in the U.S. have been falling since a peak in early August

  • Download
  • <iframe src="https://www.npr.org/player/embed/1127959596/1127959597" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Senators grill top health agencies on the U.S. response to monkeypox

  • Download
  • <iframe src="https://www.npr.org/player/embed/1123108853/1123108854" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

What happened in the Senate's hearing on the federal response to monkeypox

  • Download
  • <iframe src="https://www.npr.org/player/embed/1123024111/1123024112" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Dr. Demetre Daskalakis, White House Monkeypox response deputy coordinator, speaks during a press briefing at the White House, Wednesday, Sept. 7, 2022, in Washington. Patrick Semansky/AP hide caption

toggle caption
Patrick Semansky/AP

New data shows a high instance of monkeypox among people who are HIV positive. Above: a finger prick test for an HIV test. Chip Somodevilla/Getty Images hide caption

toggle caption
Chip Somodevilla/Getty Images

A high rate of monkeypox cases occur in people with HIV. Here are 3 theories why

  • Download
  • <iframe src="https://www.npr.org/player/embed/1121952219/1121952220" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Physician Assistant Susan Eng-Na, right, administers a monkeypox vaccine during a vaccination clinic in New York. New cases are starting to decline in New York and some other U.S. cities. Mary Altaffer/AP hide caption

toggle caption
Mary Altaffer/AP

The monkeypox outbreak may be slowing in the U.S., but health officials urge caution

  • Download
  • <iframe src="https://www.npr.org/player/embed/1119659681/1119795720" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

When did human bodies evolve to sweat? We don't know exactly when

  • Download
  • <iframe src="https://www.npr.org/player/embed/1119373338/1119373339" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The new booster shot would be an update to Pfizer's current version of the shot, which was designed for the original strain of the coronavirus. Nam Y. Huh/AP hide caption

toggle caption
Nam Y. Huh/AP